240 related articles for article (PubMed ID: 15996578)
1. Silk fibroin as a novel coating material for controlled release of theophylline.
Bayraktar O; Malay O; Ozgarip Y; Batigün A
Eur J Pharm Biopharm; 2005 Aug; 60(3):373-81. PubMed ID: 15996578
[TBL] [Abstract][Full Text] [Related]
2. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery.
Strübing S; Metz H; Mäder K
Eur J Pharm Biopharm; 2007 Apr; 66(1):113-9. PubMed ID: 17101269
[TBL] [Abstract][Full Text] [Related]
4. Solubility and rheological behavior of silk fibroin (Bombyx mori) in N-methyl morpholine N-oxide.
Xu Y; Zhang Y; Shao H; Hu X
Int J Biol Macromol; 2005 Apr; 35(3-4):155-61. PubMed ID: 15811470
[TBL] [Abstract][Full Text] [Related]
5. Effects of film coating thickness and drug layer uniformity on in vitro drug release from sustained-release coated pellets: a case study using terahertz pulsed imaging.
Ho L; Cuppok Y; Muschert S; Gordon KC; Pepper M; Shen Y; Siepmann F; Siepmann J; Taday PF; Rades T
Int J Pharm; 2009 Dec; 382(1-2):151-9. PubMed ID: 19716407
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
Lai X; Sun C; Tian H; Zhao W; Gao L
Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
[TBL] [Abstract][Full Text] [Related]
7. Silk fibroin spheres as a platform for controlled drug delivery.
Wenk E; Wandrey AJ; Merkle HP; Meinel L
J Control Release; 2008 Nov; 132(1):26-34. PubMed ID: 18761384
[TBL] [Abstract][Full Text] [Related]
8. Silk fibroin matrices for the controlled release of nerve growth factor (NGF).
Uebersax L; Mattotti M; Papaloïzos M; Merkle HP; Gander B; Meinel L
Biomaterials; 2007 Oct; 28(30):4449-60. PubMed ID: 17643485
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
10. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
11. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
[TBL] [Abstract][Full Text] [Related]
12. [The preparation and properties of Modified silk fibroin membranes by chitosan].
Liu L; Wu Z; Li P; Cai S; Chen X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):587-90. PubMed ID: 15357438
[TBL] [Abstract][Full Text] [Related]
13. Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery.
Fan LF; He W; Chang YZ; Xiang B; Du Q; Wang F; Qin M; Cao DY
Int J Pharm; 2009 Jun; 375(1-2):8-15. PubMed ID: 19457627
[TBL] [Abstract][Full Text] [Related]
14. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets.
Cerea M; Zheng W; Young CR; McGinity JW
Int J Pharm; 2004 Jul; 279(1-2):127-39. PubMed ID: 15234801
[TBL] [Abstract][Full Text] [Related]
15. pH-sensitive multiwalled carbon nanotube dispersion with silk fibroins.
Kim HS; Yoon SH; Kwon SM; Jin HJ
Biomacromolecules; 2009 Jan; 10(1):82-6. PubMed ID: 19053291
[TBL] [Abstract][Full Text] [Related]
16. Characterization of enteric-coated tablets and pellets by two in vitro dissolution methods and by scanning electron microscopy.
Odegårdstuen LI; Bjerknes K; Sande SA; Waaler T
Acta Pharm Nord; 1991; 3(3):163-70. PubMed ID: 1793511
[TBL] [Abstract][Full Text] [Related]
17. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB
Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
Zhang YQ; Zhou WL; Shen WD; Chen YH; Zha XM; Shirai K; Kiguchi K
J Biotechnol; 2005 Nov; 120(3):315-26. PubMed ID: 16102867
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization of a silk fibroin-coated polyester vascular prosthesis.
Huang F; Sun L; Zheng J
Artif Organs; 2008 Dec; 32(12):932-41. PubMed ID: 19133021
[TBL] [Abstract][Full Text] [Related]
20. Molecular weight distribution and solution properties of silk fibroins with different dissolution conditions.
Cho HJ; Ki CS; Oh H; Lee KH; Um IC
Int J Biol Macromol; 2012 Oct; 51(3):336-41. PubMed ID: 22705473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
